C反応性タンパク検査の世界市場レポート 2025年

C反応性タンパク検査の市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR5.2％で43億5,000万米ドルに成長します。予測期間の成長は、肥満率の上昇、個別化医療とバイオマーカー、遠隔医療と遠隔モニタリング、病気の早期発見、ライフスタイルに関連する炎症に起因します。予測期間の主な動向には、診断検査の進歩、ウェアラブルヘルス技術、技術ソリューション、戦略的提携、インダストリー4.0のイントロダクションなどがあります。

心血管疾患（CVD）患者の増加がC反応性タンパク検査市場の成長を牽引すると予想されます。心血管疾患には、病的な血管、構造的問題、血栓などの心臓疾患が含まれます。CVDの正確な原因は完全には解明されていないが、いくつかの要因が開発リスクを高める可能性があります。重要な要因の一つは、食生活の乱れ、運動不足、喫煙、飲酒に起因する行動リスクであり、これらは動脈に脂肪沈着物を蓄積させ（アテローム性動脈硬化症）、血栓のリスクを高める。これらの行動リスクは、血圧、グルコース値、血中脂質、体重増加、肥満の上昇につながります。CVD患者の増加に伴い、コレステロール検査と同様に、心血管疾患の可能性を診断または予測するC反応性タンパク検査の需要が増加しています。例えば、2023年12月、Institute for Health Metrics and Evaluationは、2022年の心血管疾患による世界の死亡者数は1,980万人に達し、虚血性心疾患による死亡者数は人口10万人当たり108.8人であったと報告しました。収縮期血圧の高値は、CVDに関連する障害調整生存年（DALY）の主な要因であり、一方、食事リスクと大気汚染は、この世界の問題を悪化させる重要な行動・環境要因として浮上しました。

臨床試験の増加がC反応性タンパク検査市場をさらに押し上げると予想されます。臨床試験は、C反応性タンパク検査のような診断手順を含む医療介入の安全性、有効性、潜在的な利益を評価する上で重要な役割を果たしています。これらの臨床試験は、心血管疾患の診断や心臓関連疾患のリスク予測におけるCRP検査の精度や有効性の評価に役立っています。2023年5月現在、ClinicalTrials.govには452,604件の臨床試験が登録されており、64,838件が積極的に参加者を求めています。このような臨床試験の増加は、C反応性タンパク検査の重要性の高まりを裏付けるものであり、市場の拡大に貢献しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場-金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界成長分析と戦略分析フレームワーク

• 世界のC反応性タンパク検査PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のC反応性タンパク検査市場成長率分析
• 世界のC反応性タンパク検査市場の実績：規模と成長, 2019-2024
• 世界のC反応性タンパク検査市場の予測：規模と成長, 2024-2029, 2034F
• 世界のC反応性タンパク検査総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のC反応性タンパク検査市場：アッセイタイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 酵素免疫測定法（ELISA）
• 化学発光免疫測定法（CLIA）
• 免疫比濁アッセイ
• 世界のC反応性タンパク検査市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 糖尿病
• 関節リウマチ
• 心血管疾患
• 炎症性腸疾患
• がん
• その他の用途
• 世界のC反応性タンパク検査市場：最終用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• クリニック
• 病院
• 診断検査室
• 世界のC反応性タンパク検査市場：酵素免疫測定法（ELISA）のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 直接ELISA
• 間接ELISA
• サンドイッチELISA
• 世界のC反応性タンパク検査市場：化学発光免疫測定法（CLIA）のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ルミノメーターベースのCLIA
• 自動化CLIAシステム
• 世界のC反応性タンパク検査市場：免疫比濁アッセイのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 比濁法に基づく免疫比濁アッセイ
• ラテックス凝集免疫比濁法

第7章 地域別・国別分析

• 世界のC反応性タンパク検査市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のC反応性タンパク検査市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• C反応性タンパク検査市場：競合情勢
• C反応性タンパク検査市場：企業プロファイル
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • F Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • Siemens AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Abbott Laboratories
• Aidian Oy
• Boditech Med Inc.
• Horiba Ltd.
• Laboratory Corporation
• Merck KGAA
• Randox Laboratories Limited
• Getein Biotech Inc.
• Bio-Rad Laboratories Inc.
• DiaSorin S.p.A.
• Eurofins Scientific SE
• Inova Diagnostics Inc.
• Luminex Corporation
• Sekisui Diagnostics LLC
• Sysmex Corporation

第32章 世界市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 市場の最近の動向

第35章 市場の潜在力が高い国、セグメント、戦略

• C反応性タンパク検査市場2029年-最も新しい機会を提供する国
• C反応性タンパク検査市場2029年-最も新しい機会を提供するセグメント
• C反応性タンパク検査市場2029年-成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

C-reactive protein (CRP) testing is a diagnostic procedure that assesses the concentration of CRP in the bloodstream, a protein produced by the liver in response to inflammation. In cases of injury or infection, the body initiates inflammation as a protective mechanism. CRP testing is primarily employed to identify inflammation resulting from infections.

The primary assay methods utilized in the CRP testing market include enzyme-linked immunosorbent assay (ELISA), chemiluminescence immunoassay (CLIA), and immunoturbidimetric assays. ELISA, for instance, is a technique employed to quantitatively measure human CRP levels in serum, aiding in the monitoring of conditions such as rheumatic fever and inflammatory processes. ELISA serves as a biological assay focusing on the measurement of antibodies, antigens, proteins, and glycoproteins. CRP testing is widely applied in clinical settings, hospitals, and diagnostic laboratories, contributing to the diagnosis and monitoring of various conditions such as diabetes, rheumatoid arthritis, cardiovascular diseases, inflammatory bowel disease, cancer, and others.

The c-reactive protein testing market research report is one of a series of new reports from The Business Research Company that provides c-reactive protein testing market statistics, including c-reactive protein testing industry global market size, regional shares, competitors with an c-reactive protein testing market share, detailed c-reactive protein testing market segments, market trends and opportunities, and any further data you may need to thrive in the c-reactive protein testing industry. This c-reactive protein testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The c-reactive protein testing market size has grown steadily in recent years. It will grow from $3.45 billion in 2024 to $3.55 billion in 2025 at a compound annual growth rate (CAGR) of 2.9%. The growth in the historic period can be attributed to increased inflammatory disease prevalence, cardiovascular risk assessment, increased aging population, increased healthcare infrastructure, and healthcare screening programs.

The c-reactive protein testing market size is expected to see strong growth in the next few years. It will grow to $4.35 billion in 2029 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to rising obesity rates, personalized medicine and biomarkers, telehealth and remote monitoring, early disease detection, and lifestyle-related inflammation. Major trends in the forecast period include diagnostic testing advancements, wearable health technology, technological solutions, strategic collaborations, and industry 4.0 introduction.

The rise in cardiovascular disease (CVD) cases is expected to drive the growth of the C-reactive protein testing market. Cardiovascular diseases encompass heart conditions such as diseased vessels, structural issues, and blood clots. While the exact cause of CVD is not fully understood, several factors can increase the risk of developing it. One significant factor is behavioral risk, stemming from poor diet, insufficient physical activity, smoking, and alcohol consumption, which leads to the buildup of fatty deposits in the arteries (atherosclerosis) and heightens the risk of blood clots. These behavioral risks contribute to elevated blood pressure, glucose levels, blood lipids, weight gain, and obesity. As CVD cases rise, there is an increasing demand for C-reactive protein testing to diagnose or predict the likelihood of cardiovascular issues, similar to cholesterol testing. For example, in December 2023, the Institute for Health Metrics and Evaluation reported that global deaths from cardiovascular diseases reached 19.8 million in 2022, with ischemic heart disease accounting for 108.8 deaths per 100,000 people. High systolic blood pressure was the leading contributor to disability-adjusted life years (DALYs) associated with CVD, while dietary risks and air pollution emerged as significant behavioral and environmental factors exacerbating this global issue.

The increasing number of clinical trials is anticipated to further boost the c-reactive protein testing market. Clinical trials play a crucial role in assessing the safety, efficacy, and potential benefits of medical interventions, including diagnostic procedures like c-reactive protein testing. These trials are instrumental in evaluating the accuracy and efficacy of CRP testing in diagnosing cardiovascular diseases and predicting the risk of heart-related conditions. As of May 2023, there are 452,604 clinical studies registered on ClinicalTrials.gov, with 64,838 actively seeking participants, marking a notable increase from early 2021. This rise in clinical trials underscores the growing importance of c-reactive protein testing, contributing to the market's expansion.

A noteworthy trend in the c-reactive protein testing market is the technological advancement in measuring devices. Key players in the market are prioritizing technological innovation to strengthen their market positions. These companies are integrating next-generation c-reactive testing technologies into their methods, providing advanced solutions with benefits like maximum output and multiple usages. For example, Aidian, a Finnish-based diagnostic tests and solutions company, introduced the QuikRead go wrCRP & wrCRP+Hb kits in February 2022. This kit delivers two results, a wide range of CRP and Hb, from a single sample with one analysis. The wide-range CRP test allows for CRP readings that assess conditions like neonatal sepsis, predict disease severity in COPD, and aid in cardiovascular risk assessment. This technological advancement reflects a commitment to offering efficient and comprehensive c-reactive protein testing solutions.

Key players in the c-reactive protein testing market are prioritizing innovation by introducing new technological treatments, such as the C-Reactive Protein antigen test, to enhance their market standing and profitability. The C-Reactive Protein (CRP) antigen test is a blood test designed to measure the body's level of C-Reactive Protein, a protein produced by the liver in response to inflammation. LumiraDx Healthcare Pvt Ltd., an India-based medical technology company, launched the C-Reactive Protein antigen test in November 2022. This microfluidic immunoassay offers a quick and simple way to measure CRP levels in whole blood, providing an automated in vitro diagnostic test for healthcare professionals to use in close proximity to patients.

In June 2022, Pfizer Inc., a US-based pharmaceutical and biotechnology company, acquired ReViral Ltd. for $525 million. This acquisition enhances Pfizer's anti-infective portfolio and reinforces its commitment to developing medicines and vaccines to combat respiratory syncytial virus (RSV). ReViral Ltd. is a UK-based biotech company that specializes in innovative therapies for viral diseases and C-reactive protein (CRP) testing.

Major companies operating in the c-reactive protein testing market include Thermo Fisher Scientific Inc., F Hoffmann-La Roche AG, Danaher Corporation, Quest Diagnostics Incorporated, Siemens AG, Abbott Laboratories, Aidian Oy, Boditech Med Inc., Horiba Ltd., Laboratory Corporation, Merck KGAA, Randox Laboratories Limited, Getein Biotech Inc., Bio-Rad Laboratories Inc., DiaSorin S.p.A., Eurofins Scientific SE, Inova Diagnostics Inc., Luminex Corporation, Sekisui Diagnostics LLC, Sysmex Corporation, Tosoh Corporation, Trinity Biotech Plc, WerfenLife Group LLC, ZEUS Scientific Inc., BioMerieux SA, Biomerica Inc., Gold Standard Diagnostics Corp., Immunodiagnostic Systems Holdings PLC, Nova Biomedical Corporation

North America was the largest region in the c-reactive protein testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the c-reactive protein testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the c-reactive protein testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

The c-reactive protein testing market includes revenues earned by entities by devices and reagents. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

C-Reactive Protein Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on c-reactive protein testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for c-reactive protein testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The c-reactive protein testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Assay Type: Enzyme-Linked Immunosorbent Assay (ELISA); Chemiluminescence Immunoassay (CLIA); Immunoturbidimetric Assays
• 2) By Application: Diabetes; Rheumatoid Arthritis; Cardiovascular Disease; Inflammatory Bowel Disease; Cancer; Other Applications
• 3) By End Use: Clinics; Hospitals; Diagnostic Laboratories
• Subsegments:
• 1) By Enzyme-Linked Immunosorbent Assay (ELISA): Direct ELISA; Indirect ELISA; Sandwich ELISA
• 2) By Chemiluminescence Immunoassay (CLIA): Luminometer-Based CLIA; Automated CLIA Systems
• 3) By Immunoturbidimetric Assays: Nephelometry-Based Immunoturbidimetric Assays; Latex Agglutination Immunoturbidimetric Assays
• Companies Mentioned: Thermo Fisher Scientific Inc.; F Hoffmann-La Roche AG; Danaher Corporation; Quest Diagnostics Incorporated; Siemens AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. C-Reactive Protein Testing Market Characteristics

3. C-Reactive Protein Testing Market Trends And Strategies

4. C-Reactive Protein Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global C-Reactive Protein Testing Growth Analysis And Strategic Analysis Framework

• 5.1. Global C-Reactive Protein Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global C-Reactive Protein Testing Market Growth Rate Analysis
• 5.4. Global C-Reactive Protein Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global C-Reactive Protein Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global C-Reactive Protein Testing Total Addressable Market (TAM)

6. C-Reactive Protein Testing Market Segmentation

• 6.1. Global C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Enzyme-Linked Immunosorbent Assay (ELISA)
• Chemiluminescence Immunoassay (CLIA)
• Immunoturbidimetric Assays
• 6.2. Global C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diabetes
• Rheumatoid Arthritis
• Cardiovascular Disease
• Inflammatory Bowel Disease
• Cancer
• Other Applications
• 6.3. Global C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clinics
• Hospitals
• Diagnostic Laboratories
• 6.4. Global C-Reactive Protein Testing Market, Sub-Segmentation Of Enzyme-Linked Immunosorbent Assay (ELISA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Direct ELISA
• Indirect ELISA
• Sandwich ELISA
• 6.5. Global C-Reactive Protein Testing Market, Sub-Segmentation Of Chemiluminescence Immunoassay (CLIA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Luminometer-Based CLIA
• Automated CLIA Systems
• 6.6. Global C-Reactive Protein Testing Market, Sub-Segmentation Of Immunoturbidimetric Assays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nephelometry-Based Immunoturbidimetric Assays
• Latex Agglutination Immunoturbidimetric Assays

7. C-Reactive Protein Testing Market Regional And Country Analysis

• 7.1. Global C-Reactive Protein Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global C-Reactive Protein Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific C-Reactive Protein Testing Market

• 8.1. Asia-Pacific C-Reactive Protein Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China C-Reactive Protein Testing Market

• 9.1. China C-Reactive Protein Testing Market Overview
• 9.2. China C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India C-Reactive Protein Testing Market

• 10.1. India C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan C-Reactive Protein Testing Market

• 11.1. Japan C-Reactive Protein Testing Market Overview
• 11.2. Japan C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia C-Reactive Protein Testing Market

• 12.1. Australia C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia C-Reactive Protein Testing Market

• 13.1. Indonesia C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea C-Reactive Protein Testing Market

• 14.1. South Korea C-Reactive Protein Testing Market Overview
• 14.2. South Korea C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe C-Reactive Protein Testing Market

• 15.1. Western Europe C-Reactive Protein Testing Market Overview
• 15.2. Western Europe C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK C-Reactive Protein Testing Market

• 16.1. UK C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany C-Reactive Protein Testing Market

• 17.1. Germany C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France C-Reactive Protein Testing Market

• 18.1. France C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy C-Reactive Protein Testing Market

• 19.1. Italy C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain C-Reactive Protein Testing Market

• 20.1. Spain C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe C-Reactive Protein Testing Market

• 21.1. Eastern Europe C-Reactive Protein Testing Market Overview
• 21.2. Eastern Europe C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia C-Reactive Protein Testing Market

• 22.1. Russia C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America C-Reactive Protein Testing Market

• 23.1. North America C-Reactive Protein Testing Market Overview
• 23.2. North America C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA C-Reactive Protein Testing Market

• 24.1. USA C-Reactive Protein Testing Market Overview
• 24.2. USA C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada C-Reactive Protein Testing Market

• 25.1. Canada C-Reactive Protein Testing Market Overview
• 25.2. Canada C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America C-Reactive Protein Testing Market

• 26.1. South America C-Reactive Protein Testing Market Overview
• 26.2. South America C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil C-Reactive Protein Testing Market

• 27.1. Brazil C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East C-Reactive Protein Testing Market

• 28.1. Middle East C-Reactive Protein Testing Market Overview
• 28.2. Middle East C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa C-Reactive Protein Testing Market

• 29.1. Africa C-Reactive Protein Testing Market Overview
• 29.2. Africa C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. C-Reactive Protein Testing Market Competitive Landscape And Company Profiles

• 30.1. C-Reactive Protein Testing Market Competitive Landscape
• 30.2. C-Reactive Protein Testing Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Siemens AG Overview, Products and Services, Strategy and Financial Analysis

31. C-Reactive Protein Testing Market Other Major And Innovative Companies

• 31.1. Abbott Laboratories
• 31.2. Aidian Oy
• 31.3. Boditech Med Inc.
• 31.4. Horiba Ltd.
• 31.5. Laboratory Corporation
• 31.6. Merck KGAA
• 31.7. Randox Laboratories Limited
• 31.8. Getein Biotech Inc.
• 31.9. Bio-Rad Laboratories Inc.
• 31.10. DiaSorin S.p.A.
• 31.11. Eurofins Scientific SE
• 31.12. Inova Diagnostics Inc.
• 31.13. Luminex Corporation
• 31.14. Sekisui Diagnostics LLC
• 31.15. Sysmex Corporation

32. Global C-Reactive Protein Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The C-Reactive Protein Testing Market

34. Recent Developments In The C-Reactive Protein Testing Market

35. C-Reactive Protein Testing Market High Potential Countries, Segments and Strategies

• 35.1 C-Reactive Protein Testing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 C-Reactive Protein Testing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 C-Reactive Protein Testing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer